Thomas J. Braun
About
In The Last Decade
Thomas J. Braun
19 papers receiving 802 citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Surgery 469
- Oncology 176
- Pathology and Forensic Medicine 172
- Pulmonary and Respiratory Medicine 127
- Pediatrics, Perinatology and Child Health 124
Countries citing papers authored by Thomas J. Braun
This map shows the geographic impact of Thomas J. Braun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. Braun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. Braun more than expected).
Fields of papers citing papers by Thomas J. Braun
This network shows the impact of papers produced by Thomas J. Braun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. Braun. The network helps show where Thomas J. Braun may publish in the future.
Co-authorship network of co-authors of Thomas J. Braun
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. Braun. A scholar is included among the top collaborators of Thomas J. Braun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. Braun. Thomas J. Braun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 4 | |
| 3 | 74 | |
| 4 | 3 | |
| 5 | 3 | |
| 6 | 9 | |
| 7 | 20 | |
| 8 | 35 | |
| 9 | 3 | |
| 10 | 35 | |
| 11 | A phase II trial of recombinant tumor necrosis factor in patients with metastatic colorectal adenocarcinoma: a Southwest Oncology Group study. | 21 |
| 12 | 56 | |
| 13 | 7 | |
| 14 | 7 | |
| 15 | 14 | |
| 16 | 2 | |
| 17 | Biochemical effects of 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil and 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine in mouse leukemic cells sensitive and resistant to 1-beta-D-arabinofuranosylcytosine. | 18 |
| 18 | Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and Vomiting breakdown → | 555 |
| 19 | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.